Stephen Hoge
Net worth: 77 M $ as of 31/05/2026
Net worth: 77 M $ as of 31/05/2026
Currently, Stephen Hoge occupies the position of President at Moderna, Inc. and President at ModernaTX, Inc. (a subsidiary of Moderna, Inc.). He is also on the board of Axcella Health, Inc. and President for ModernaTX, Inc. In his past career he was Partner at McKinsey & Co., Inc. He received an undergraduate degree from Amherst College and a doctorate from The University of California, San Francisco.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MODERNA, INC. 0.41% | 01/06/2026 | 1,639,897 ( 0.41% ) | 77 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| MODERNA, INC. | President | 01/11/2024 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | President | - |
| Companies | Position | End |
|---|---|---|
| AXCA HEALPAR | Director/Board Member | 19/05/2022 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/12/2012 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions